By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Room temperature version of coagulation factor

Novo Nordisk UK has announced that NovoSeven – its recombinant activated factor VII product available for the treatment of bleeding episodes in people with haemophilia with inhibitors – is now available as a room temperature stable formulation from today onwards. This replaces the previous formulation, which required refrigeration.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories 
  • Customised email alerts straight to your inbox (30+ alerts available) 
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units